| 000 | 01829 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516051818.0 | ||
| 264 | 0 | _c20120103 | |
| 008 | 201201s 0 0 eng d | ||
| 022 | _a1557-9077 | ||
| 024 | 7 |
_a10.1089/thy.2011.0039 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLaurberg, Peter | |
| 245 | 0 | 0 |
_aSustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy. _h[electronic resource] |
| 260 |
_bThyroid : official journal of the American Thyroid Association _cSep 2011 |
||
| 300 |
_a951-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntithyroid Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aDenmark |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFeasibility Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGraves Disease _xdiagnosis |
| 650 | 0 | 4 |
_aGraves Ophthalmopathy _xdiagnosis |
| 650 | 0 | 4 | _aHormone Replacement Therapy |
| 650 | 0 | 4 | _aHospitals, University |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins, Thyroid-Stimulating _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethimazole _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPropylthiouracil _xadministration & dosage |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aThyroxine _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBerman, Dalia C | |
| 700 | 1 | _aAndersen, Stig | |
| 700 | 1 | _aBülow Pedersen, Inge | |
| 773 | 0 |
_tThyroid : official journal of the American Thyroid Association _gvol. 21 _gno. 9 _gp. 951-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/thy.2011.0039 _zAvailable from publisher's website |
| 999 |
_c21079129 _d21079129 |
||